News + Filings Transactions
|
VOGELBAUM MARTIN
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
09/14/2022 | Cara Therapeutics, Inc. | CARA | Sale | Common Stock | 10.8k | $10.28 | $111k | | 09/14/2022 |
06/02/2022 | Cara Therapeutics, Inc. | CARA | Grant | Common Stock | 23.8k | $0.00 | $0 | | 06/02/2022 |
06/02/2022 | Cara Therapeutics, Inc. | CARA | Grant | Common Stock | 11.9k | $0.00 | $0 | | 06/02/2022 |
06/02/2022 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 34k | $8.42 | $286.2k | | 06/02/2022 |
06/07/2021 | Cara Therapeutics, Inc. | CARA | Sale | Common Stock | 8.6k | $13.05 | $112.8k | | 06/03/2021 |
06/03/2021 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 21.6k | $13.06 | $282.1k | | 06/03/2021 |
06/03/2021 | Cara Therapeutics, Inc. | CARA | Grant | Common Stock | 14.4k | $0.00 | $0 | | 06/03/2021 |
11/17/2020 | Cara Therapeutics, Inc. | CARA | Sale | Common Stock | 6k | $16.09 | $96.5k | | 11/17/2020 |
06/04/2020 | Cara Therapeutics, Inc. | CARA | Grant | Common Stock | 14.4k | $0.00 | $0 | | 06/04/2020 |
06/04/2020 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 21.6k | $15.62 | $337.4k | | 06/04/2020 |
06/04/2019 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 9k | $20.44 | $184k | | 06/04/2019 |
06/04/2019 | Cara Therapeutics, Inc. | CARA | Grant | Common Stock | 6k | $0.00 | $0 | | 06/04/2019 |
06/04/2019 | Cara Therapeutics, Inc. | CARA | Grant | Common Stock | 6k | $0.00 | $0 | | 06/04/2019 |
06/06/2018 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 18k | $16.07 | $289.3k | | 06/06/2018 |
06/21/2017 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 15k | $19.50 | $292.5k | | 06/21/2017 |
06/15/2016 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 15k | $5.32 | $79.8k | | 06/15/2016 |
03/17/2016 | Cara Therapeutics, Inc. | CARA | Purchase | Common Stock | 247.7k | $4.93 | $1.2M | By Partnership | 03/16/2016 |
03/16/2016 | Cara Therapeutics, Inc. | CARA | Purchase | Common stock | 152.3k | $4.78 | $727.8k | By Partnership | 03/16/2016 |
06/24/2015 | ROCKET PHARMACEUTICALS, INC. | RCKT | Grant | Stock Options (Right to Buy) | 12k | $5.03 | $60.4k | | 06/24/2015 |
06/08/2015 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 13.5k | $9.94 | $134.2k | | 06/08/2015 |
05/15/2014 | NephroGenex, Inc. | NRX | Grant | Options to Purchase Common Stock | 3.1k | $11.90 | $36.6k | | 05/15/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Series A Preferred Stock | 106.7k | $0.00 | $0 | See footnote | 02/14/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Series A Preferred Stock | 1.2M | $0.00 | $0 | See footnote | 02/14/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Convertible Promissory Note | 106.7k | $0.00 | $0 | See footnote | 02/14/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Convertible Promissory Note | 1.2M | $0.00 | $0 | See footnote | 02/14/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Series A Preferred Stock | 494.4k | $0.00 | $0 | See footnote | 02/14/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Series A Preferred Stock | 5.6M | $0.00 | $0 | See footnote | 02/14/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Grant | Common Stock | 181k | $0.00 | $0 | See footnote | 02/14/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Common Stock | 203.4k | $0.00 | $0 | See footnote | 02/14/2014 |
02/14/2014 | NephroGenex, Inc. | NRX | Conversion | Common Stock | 942.5k | $0.00 | $0 | See footnote | 02/14/2014 |
02/05/2014 | Cara Therapeutics, Inc. | CARA | Conversion | Series D Preferred Stock | 6.1M | $0.00 | $0 | By Partnership | 02/05/2014 |
02/05/2014 | Cara Therapeutics, Inc. | CARA | Purchase | Common Stock | 225.8k | $11.00 | $2.5M | By Partnership | 02/05/2014 |
02/05/2014 | Cara Therapeutics, Inc. | CARA | Conversion | Common Stock | 2.4M | $0.00 | $0 | By Partnership | 02/05/2014 |
01/30/2014 | Cara Therapeutics, Inc. | CARA | Grant | Stock Option (Right to Buy) | 20k | $11.00 | $220k | | 01/30/2014 |
|